| Name | Title | Contact Details |
|---|
Eastern Ct Health Network is a Manchester, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CitiMed is a healthcare provider with over 100 board certified healthcare providers offering a full range of medical services, including primary care, neurosurgery, and pain management, with 20 locations in Queens, the Bronx, and White Plains.
EnovateIT is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Morehead Memorial Hospital operates as a community hospital that provides various medical services to patients in Eden, North Carolina. It offers birthing center, cancer center, cardiac rehabilitation and chronic disease management, cardiopulmonary, day hospital, diagnostic imaging, emergency, intensive coronary care unit, laboratory, nursing center, occupational health, rehabilitation, sleep center, diagnostic center, wound healing center, and women’s diagnostic services. The company was founded in 1960 and is headquartered in Eden, North Carolina.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.